SlideShare ist ein Scribd-Unternehmen logo
1 von 40
AEROSOL
BY
ASHUTOSH GUPTA
M.Pharm
Student in BIT Mesra Ranchi
INTRODUCTION
 Aerosol or Pressurized package is defined as ―A system that depends on the
power of a compressed gas or liquefied gas to expel the contents from the
container.
 containing active ingredients dissolved, suspended or emulsified in a
propellant or a mixture of solvent and propellant and intended for oral or
topical administration or for administration into the eye, nose, ear, rectum and
vagina.
 In 1942 - First aerosol was developed. (insecticide)
 In 1950 - Pharmaceutical aerosol for topical administration was developed.
 In 1955 - Aerosol for the local activity in the respiratory tract was developed
(Epinephrine).
ADVANTAGE
 When sterility is an important factor, it can be maintained while a dose is being
dispensed.
 The medication can be delivered directly to the affected
 Area in a desired form. (localized action)
 Irritation produced by the mechanical application of topical medication is reduced
or eliminated.
 Easy and convenience of application.
 Application of medication in thin layer.
 Rapid response to the medicament.
DISADVANTAGE
 Expensive.
 Chlorofluorocarbon propellants cause Ozone
 layer depletion.
 In flammability
 Toxicity
 Explosivity
COMPONENTS OF AEROSOL PACKAGE
 An aerosol product consists of the following component parts-
 Propellent
 Container
 Valve & actuator
 Product concentrate
PROPELLENT
 Responsible for developing
 Proper pressure within the container.
 Provide driving force to expel the
 product from the container.
TYPES OF PROPELLANTS
 Liquefied gases Propellants
 Compressed gases Propellants
LIQUIDFIED GASES PROPELLANTS
 Liquified propellants are gases that exist as liquids under pressure.
 Because the aerosol is under pressure propellant exists mainly as a liquid, but it
will also be in the head space as a gas.
 The product is used up as the valve is opened, some of the liquid propellant turns
to gas and keeps the head space full of gas.
 In this way the pressure in the can remains essentially constant and the spray
performance is maintained throughout the life of the aerosol.
CHLORO FLUORO CARBON
 Propellant of choice for oral and inhalation .
Advantages
 Chemical inertness
 Lack of toxicity
 Non flammability.
 Lack of explosiveness
Disadvantages
 High cost
 It depletes the ozone layer
Examples: Trichloromonofluoromethane -Propellant11
Dichlorodifluoromethane -Propellant 12
Dichlorotetrafluoroethane- Propellant 114
HYDROCARBONS
 Can be used for water based aerosols and topical use
Advantages
 Inexpensive
 Excellent solvents
 It does not cause ozone depletion
Disadvantage
 Inflammable
 Unknown toxicity produced
Example: Propane-propellants A 108
 Isobutane-propellant A 31
 Butane-propellent A 17
HYDROCHLORO CARBON AND HYDRO CHLORO FLUORO CARBANS
 These compounds break down in the atmosphere at faster rate than CFCs.
 Lower ozone destroying effect.
Advantages
 Low inhalation toxicity
 High chemical stability
 High purity
 Not ozone depleting
Disadvantages
 Poor solvent
 High cost
Example: Heptafluoro propane (HFA-227)
 Tetrafluoroethene (HFA-134a)
 Difluoroethane- Propellant 152a
 Chlorodifluoromethane - Propellant 22
 Chlorodifluoromethane - Propellant 142 b
 All propellants are designed by three digits(000).
 The first digit represents the one less than the number of carbon atoms(‘C’-1) in the compound.
 The second digit represents the one more than the number of hydrogen atoms (‘H’+1) in the compound.
 The last third digit represents the number of fluorine atoms in the compound.
 The number of chlorine atoms (for CFCs) in the compound can be found by subtracting the sum of the
fluorine and the hydrogen atoms from the total number of atoms that can be added to saturated the carbon
chain.
 In case of isomers, the most symmetrical one is indicated by the number alone. As the isomer becomes more
and more asymmetrical, the letter a, b, c etc. follows the number.
 For cyclic compound, a lowercase c is used before the number.
COMPRESSED GAS PROPALLENT
 Compressed gas propellants occupy the head space above the liquid in the can.
 When the aerosol valve is opened the gas 'pushes' the liquid out of the can.
 The amount of gas in the headspace remains the same but it has more space,
and as a result the pressure will drop during the life of the can.
 Spray however by careful choice of the aerosol valve and actuator.
 They must be able to withstand pressures as high as 140 to 180 psig (pounds per
sq. inch gauge) at 130 ° F.
AEROSOL CONTAINERS
 A . Metals
 Tinplated steel
 Aluminum
 Stainless steel
 Glass
 Uncoated glass
 Plastic coated glass
Teen plated steel container
 It consist of a sheet of steel plate, this sheet is coated with tin by electrolytic
process .
 The coated sheet is cut into three pieces ( top , bottom and
 body) .
 The top, bottom are attached to body by soldering .
 When required it is coated with organic material usually
 oleoresin, phenolic , vinyl or epoxy coating .
 Welding eliminates soldering process, Saves considerable manufacturing time
and decreases the product/container interaction.
Aluminium container
 Used for inhalation and topical aerosols .
 Manufactured by impact extrusion process.
 Light in weight, less fragile, Less incompatibility due to its seamless nature.
 Greater resistance to corrosion.
 Pure water and ethanol cause corrosion to the aluminium container.
 Added resistance can be obtained by coating inside of the container with
organic coating like phenolic , vinyl or epoxy and polyamide resins.
Stainless steel container
 Used for inhalation aerosols
Advantage :
 Extremely Strong.
 Resistant to many materials.
 No need for internal coating
Disadvantage :
 Costly
Glass container
 These containers are preferred because of its Aesthetic value and absence of
incompatibilities.
 These containers are limited to the products having a lower
 pressure (33 psig) and lower percentage of the propellant.
 Used for topical and MDI aerosols.
 Two types of glass aerosol containers-
i) Uncoated glass container:
 Less cost and high clarity and contents can be viewed at all times.
ii) Plastic coated glass containers:
 These are protected by plastic coating that prevents the
 glass from shattering in the event of breakage.
VALVS
 Easy to open and close .
 Capable of delivering the content in the desired form such
 as spray, foam, solid stream etc.
 It can deliver a given amount of medicament .
TYPES OF VALVES :
 Continuous spray valve
 Metering valves
 VALVE ASSAMBLY
CONTINUOUS SPRAY VALVE
CONTINUOUS SPRAY VALVE
 Used for topical aerosols.
 Valves assembly consists:
 Ferrule or mounting cup
 Valve body or housing
 Stem
 Dip tube
 Gasket
 Spring
FERRULE OR MOUNTING CUP :
 Used to attach valve to container.
 Made from Tin plated steel, Al, Brass.
 Under side of the valve cup is coated with single or double epoxy or vinyl resins.
VALVE BODY OR HOUSING :
 Made up of Nylon or Derlin and contains a opening at the
 point of attachment of dip tube. (0.013 to 0.080 inch)
STEM:
 Made from Nylon or Derlin , brass and stainless steel can
 also be used. (orifice - 0.013 to 0.030 inch).
GASKET:
 Made from Buna-N and neoprene rubber.
SPRING:
 Made from Stainless steel.
 Used to hold gasket in place.
DIP TUBE:
 Made from Poly ethylene or poly propylene.
 Inner diameter 0.120 – 0.125 inch.
 However, for Capillary dip tube inner diameter is 0.050 inch and for highly viscous products it is
0.195 inch.
METERING VALVE
 Used for dispensing of potent medication
 Operates on theprinciple of a chamber whose size determines the
amount of medication dispensed.
 Approximately 50 to 150 mg ± 10 % of liquid materials can be dispensed
at one time with the use of such valve.
ACTUATORS
 These are specially designed buttons which helps in delivering the drug in desired
form i.e., spray, wet stream, foam or solid stream.
TYPES OFACTUATORS:
 Spray actuators
 Foam actuators
 Solid steam actuators
 Special actuators
SPRAY ACTUATORS:
 It can be used for topical preparation, such as antiseptics, local anesthetics and spray on bandages
etc.
 It allows the stream of product concentrate and propellant to pass through various openings and
dispense as spray. FOAM ACTUATORS:
 It consists of large orifice which ranges from 0.070—0.125 inch.
SOLID STREAM ACTUATORS:
 These actuators are required for dispensing semi solid products such as ointments.
SPECIALACTUATORS:
 These are used for a specific purpose.
 It delivers the medicament to the appropriate site of action such as throat, nose, dental and eyes
etc.
Application of aerosol
 The use of aerosol as a dosage foam is particularly important in a administration of drug via a
pulmonary system.
 In addition to local effects, systemic may be obtain if the drug absorbed in to a bloodstream from
the lungs.
 Topical preparations are also suited for presentation as aerosol.
 They are used for spray bandages and for application of drugs into various body cavities.
 They are used for administration of drug such as local anaesthetic, local antiseptic, local
analgesics and anti-inflammatory drug.
 They are used for cosmetics preparation such as perfumes.
 They are used to spray disinfectant, deodorizers, air sanitizers.
 The medicament can be delivered to the affect area such as burn and wound.
 It also minimizes the discomfort caused by manual and mechanical application.
EVALUATION AEROSOL
 Aerosol are pressurized packages and many tests are necessary to ensure proper performance of
the package and safety during use and storage.
 Pharmaceutical aerosols can be evaluated by a series of physical, chemical and biological tests,
including:
Flammability and combustibility:
 Flash point
 Flame Projection
Physicochemical characteristics:
 Vapor pressure
 Density
 Moisture content
 Identification of Propellants
 Concentrate- propellent ratio
Performance:
 Aerosol valve discharge rate
 Spray pattern
 Dosage with metered valves
 Net contents
 Foam stability
 Particle size determination
 Leakage
Biological testing:
 Therapeutic activity
 Toxicity studies
Flammability and combustibility:
Flash point
 Apparatus: Tag Open Cup Apparatus Product is chilled to – 25°F and test liquid
 temperature is allowed to increase slowly and the temperature at which vapours
ignite is called as Flash Point.
Flame Projection
 Product is sprayed for 4 secs into a flame and the flame is extended, exact length
is measured with a ruler.
Property Method
1. Vapor Pressure » Pressure gauge
» Can Puncturing Device.
2. Density » Hydrometer,
» Pycnometer.
3. Moisture » Karl Fisher Method,
» Gas Chromatography.
4. Identification
of
propellants
» Gas Chromatography,
» IR Spectroscopy.
•Physicochemical characteristics:
Performance:
Aerosol valve discharge rate
 Contents of the aerosol product of known weight is discharged for specific period
of time.
 By reweighing the container after the time limit, the change in the weight per
time dispensed gives the discharge rate (g/sec).
Spray pattern
 The method is based on the impingement of spray on piece of paper that has been
treated with Dye-Talc mixture.
 The particles that strike the paper
 cause the dye to go into solution and to be adsorbed onto paper giving a record of
spray for comparison purpose.
Dosage with metered valves
 Reproducibility of dosage can be determined by:
 »Assay techniques
 »Accurate weighing of filled container followed by dispensing of several doses.
Containers are then reweighed and difference in weight divided by number of
doses dispensed gives average dose.
Net Contents:
 Tared cans that have been placed onto the filling lines are reweighed and the
difference in weight is equal to the net contents.
 In Destructive method: weighing a full container and then dispensing as much of
the content as possible. The contents are then weighed. This gives the net content.
Foam stability
 Methods: » Visual Evaluation,
 » Time for given mass to penetrate the foam,
 » Time for given rod that is inserted into the foam to fall,
 » Rotational Viscometer.
Particle Size Determination
 Methods: » Cascade Impactor,
 » Light Scattering Decay.
Biological testing:
Therapeutic Activity
 » For Inhalation Aerosols: dosage of the product is determined and is related to
the particle size distribution.
 » For Topical Aerosols: is applied to test areas and adsorption of therapeutic
ingredient is determined.
Toxicity
 » For Inhalation Aerosols: exposing test animals to vapours sprayed from
aerosol container
 » For Topical Aerosols: : Irritation and Chilling effects are determined.
QUALITY CONTROL TEST OFAEROSOL
 There are following quality control test for aerosol:
-Propellants
-Valves, Actuators and Dip Tubes
-Containers
-Weight Checking
-Leak Testing
-Spray Testing
Propellants
 Vapor pressure and density of the propellant are determined and compared with
specification sheet.
Parameter Tested By
• Identification
• Purity and acceptability
Gas Chromatography,
IR Spectroscopy
Moisture, Halogen,
Non-Volatile Residue
determinations
Valves, Actuators and Dip Tubes
 Sampling is done according to standard procedures as found in Military
Standards ―MIL-STD-105D‖.
 For metered dose aerosol valves, test methods were developed by
-Aerosol Specifications Committee
-Industrial Pharmaceutical Technology Section
-Academy of Pharmaceutical Sciences.
 The objective of this test is to determine magnitude of valve delivery & degree of
uniformity between individual valves.
 Standard test solutions were proposed to rule out variation in valve delivery.
CONTAINERS
 Containers are examined for defects in lining.
 Quality control aspects includes degree of conductivity of
 electric current as measure of exposed metals.
 Glass containers examined for Flaws.
WEIGHT CHECKING
 Is done by periodically adding to the filling line tared empty aerosol
containers, which after filling with concentrate are removed & weighed.
 Same procedure is used for checking weight of Propellants being added.
LEAK TESTING
 It is a means of checking crimping of the valve and detect the defective
containers due to leakage.
 Is done by measuring the Crimp ‘s dimension & comparing.
 Final testing of valve closure is done by passing the filled containers through
water bath.
SPRAY TESTING
 Most pharmaceutical aerosols are 100% spray tested.
 This serves to clear the dip tube of pure propellant and pure concentrate.
 To check for defects in valves and spray pattern.
Aerosol Drug Delivery Systems Explained

Weitere ähnliche Inhalte

Was ist angesagt?

Aerosols formulation & Packaging
Aerosols formulation & Packaging Aerosols formulation & Packaging
Aerosols formulation & Packaging Deepak Joshi
 
Formulation and Manufacturing of Aerosols and their Evaluation
Formulation and Manufacturing of Aerosols and their EvaluationFormulation and Manufacturing of Aerosols and their Evaluation
Formulation and Manufacturing of Aerosols and their EvaluationAnurag Gupta
 
Propellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsPropellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsVIJAY SINGH
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosolsShivaram
 
Propellants
PropellantsPropellants
Propellantspharmacy
 
Tablet coating by ankita yagnik
Tablet coating by ankita yagnikTablet coating by ankita yagnik
Tablet coating by ankita yagnikAnkita Yagnik
 
Fluid bed processor, gpcg
Fluid bed processor, gpcgFluid bed processor, gpcg
Fluid bed processor, gpcgPrashant Patil
 
Parenteral production
Parenteral productionParenteral production
Parenteral productionSagar Savale
 
Aerosol Containers | Definition | Components | Manufacturing | Evaluation
Aerosol Containers | Definition | Components | Manufacturing |  EvaluationAerosol Containers | Definition | Components | Manufacturing |  Evaluation
Aerosol Containers | Definition | Components | Manufacturing | EvaluationChetan Prakash
 
Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions Dheeraj Saini
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form ROHIT YADAV
 
Filling of aerosol
Filling of aerosolFilling of aerosol
Filling of aerosolimran khan
 

Was ist angesagt? (20)

Aerosols formulation & Packaging
Aerosols formulation & Packaging Aerosols formulation & Packaging
Aerosols formulation & Packaging
 
Formulation and Manufacturing of Aerosols and their Evaluation
Formulation and Manufacturing of Aerosols and their EvaluationFormulation and Manufacturing of Aerosols and their Evaluation
Formulation and Manufacturing of Aerosols and their Evaluation
 
Propellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosolsPropellants in-pharmaceutical-aerosols
Propellants in-pharmaceutical-aerosols
 
Aerosol
AerosolAerosol
Aerosol
 
Propellents
PropellentsPropellents
Propellents
 
Aerosols
AerosolsAerosols
Aerosols
 
Aerosols
AerosolsAerosols
Aerosols
 
Aerosol final-170427090227
Aerosol final-170427090227Aerosol final-170427090227
Aerosol final-170427090227
 
Pharmaceutical aerosols
Pharmaceutical aerosolsPharmaceutical aerosols
Pharmaceutical aerosols
 
Propellants
PropellantsPropellants
Propellants
 
Tablet coating by ankita yagnik
Tablet coating by ankita yagnikTablet coating by ankita yagnik
Tablet coating by ankita yagnik
 
Fluid bed processor, gpcg
Fluid bed processor, gpcgFluid bed processor, gpcg
Fluid bed processor, gpcg
 
Parenteral production
Parenteral productionParenteral production
Parenteral production
 
Pharmaceutical aerosol
Pharmaceutical  aerosolPharmaceutical  aerosol
Pharmaceutical aerosol
 
Aerosol Containers | Definition | Components | Manufacturing | Evaluation
Aerosol Containers | Definition | Components | Manufacturing |  EvaluationAerosol Containers | Definition | Components | Manufacturing |  Evaluation
Aerosol Containers | Definition | Components | Manufacturing | Evaluation
 
Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions Formulation and manufacturing of suspensions
Formulation and manufacturing of suspensions
 
Liquid dosage form
Liquid dosage form Liquid dosage form
Liquid dosage form
 
Formulation of Emulsion
Formulation of EmulsionFormulation of Emulsion
Formulation of Emulsion
 
PHARMACEUTICAL AEROSOLS
PHARMACEUTICAL AEROSOLSPHARMACEUTICAL AEROSOLS
PHARMACEUTICAL AEROSOLS
 
Filling of aerosol
Filling of aerosolFilling of aerosol
Filling of aerosol
 

Ähnlich wie Aerosol Drug Delivery Systems Explained

Phamaceutical aerosals
Phamaceutical aerosalsPhamaceutical aerosals
Phamaceutical aerosalsG Vaishnavi
 
Pharmaceutical Aerosols
Pharmaceutical Aerosols Pharmaceutical Aerosols
Pharmaceutical Aerosols OMKARTAMBEKAR
 
Pulmonary dds - Copy.pptx
Pulmonary dds - Copy.pptxPulmonary dds - Copy.pptx
Pulmonary dds - Copy.pptxVidhi Sharma
 
Pharmaceutical Aerosols.pptx
Pharmaceutical Aerosols.pptxPharmaceutical Aerosols.pptx
Pharmaceutical Aerosols.pptxankita974745
 
Pharmaceutical aerosols by suraj mohan hnbgu 2017
Pharmaceutical aerosols by suraj mohan hnbgu 2017Pharmaceutical aerosols by suraj mohan hnbgu 2017
Pharmaceutical aerosols by suraj mohan hnbgu 2017Suraj Mohan
 
Aerosol by ankita yagnik
Aerosol by ankita yagnikAerosol by ankita yagnik
Aerosol by ankita yagnikAnkita Yagnik
 
Aerosols and it's applications
Aerosols and it's applicationsAerosols and it's applications
Aerosols and it's applicationsMosil Lubricants
 
Pulmonary drug delivery system
Pulmonary drug delivery systemPulmonary drug delivery system
Pulmonary drug delivery systemSUJITHA MARY
 
Introduction aerosol
Introduction aerosolIntroduction aerosol
Introduction aerosolAbinashpati4
 
PHARMACEUTICAL DOSAGE FORM NOTES
PHARMACEUTICAL DOSAGE FORM NOTESPHARMACEUTICAL DOSAGE FORM NOTES
PHARMACEUTICAL DOSAGE FORM NOTESEknath Babu T.B.
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.Mohammad Imran
 
B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon
 B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon  B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon
B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon M Swetha
 
Aerosol (detail study)
Aerosol (detail study)Aerosol (detail study)
Aerosol (detail study)Ravish Yadav
 

Ähnlich wie Aerosol Drug Delivery Systems Explained (20)

Phamaceutical aerosals
Phamaceutical aerosalsPhamaceutical aerosals
Phamaceutical aerosals
 
Aerosols.pptx
Aerosols.pptxAerosols.pptx
Aerosols.pptx
 
Pharmaceutical Aerosols
Pharmaceutical Aerosols Pharmaceutical Aerosols
Pharmaceutical Aerosols
 
Pulmonary dds - Copy.pptx
Pulmonary dds - Copy.pptxPulmonary dds - Copy.pptx
Pulmonary dds - Copy.pptx
 
Aerosol
AerosolAerosol
Aerosol
 
Pharmaceutical Aerosols.pptx
Pharmaceutical Aerosols.pptxPharmaceutical Aerosols.pptx
Pharmaceutical Aerosols.pptx
 
Pharmaceutical aerosols by suraj mohan hnbgu 2017
Pharmaceutical aerosols by suraj mohan hnbgu 2017Pharmaceutical aerosols by suraj mohan hnbgu 2017
Pharmaceutical aerosols by suraj mohan hnbgu 2017
 
Aerosol by ankita yagnik
Aerosol by ankita yagnikAerosol by ankita yagnik
Aerosol by ankita yagnik
 
Final yr aerosols
Final yr aerosolsFinal yr aerosols
Final yr aerosols
 
Aerosols
AerosolsAerosols
Aerosols
 
Aerosols and it's applications
Aerosols and it's applicationsAerosols and it's applications
Aerosols and it's applications
 
Aerosols1
Aerosols1Aerosols1
Aerosols1
 
Aerosol
AerosolAerosol
Aerosol
 
Pulmonary drug delivery system
Pulmonary drug delivery systemPulmonary drug delivery system
Pulmonary drug delivery system
 
Introduction aerosol
Introduction aerosolIntroduction aerosol
Introduction aerosol
 
Aerosols
AerosolsAerosols
Aerosols
 
PHARMACEUTICAL DOSAGE FORM NOTES
PHARMACEUTICAL DOSAGE FORM NOTESPHARMACEUTICAL DOSAGE FORM NOTES
PHARMACEUTICAL DOSAGE FORM NOTES
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.
 
B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon
 B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon  B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon
B.pharmacy III yr Aerosol, formulation,equipment's for filling ,Evaluatilon
 
Aerosol (detail study)
Aerosol (detail study)Aerosol (detail study)
Aerosol (detail study)
 

Kürzlich hochgeladen

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 

Kürzlich hochgeladen (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 

Aerosol Drug Delivery Systems Explained

  • 2. INTRODUCTION  Aerosol or Pressurized package is defined as ―A system that depends on the power of a compressed gas or liquefied gas to expel the contents from the container.  containing active ingredients dissolved, suspended or emulsified in a propellant or a mixture of solvent and propellant and intended for oral or topical administration or for administration into the eye, nose, ear, rectum and vagina.  In 1942 - First aerosol was developed. (insecticide)  In 1950 - Pharmaceutical aerosol for topical administration was developed.  In 1955 - Aerosol for the local activity in the respiratory tract was developed (Epinephrine).
  • 3. ADVANTAGE  When sterility is an important factor, it can be maintained while a dose is being dispensed.  The medication can be delivered directly to the affected  Area in a desired form. (localized action)  Irritation produced by the mechanical application of topical medication is reduced or eliminated.  Easy and convenience of application.  Application of medication in thin layer.  Rapid response to the medicament.
  • 4. DISADVANTAGE  Expensive.  Chlorofluorocarbon propellants cause Ozone  layer depletion.  In flammability  Toxicity  Explosivity
  • 5. COMPONENTS OF AEROSOL PACKAGE  An aerosol product consists of the following component parts-  Propellent  Container  Valve & actuator  Product concentrate
  • 6. PROPELLENT  Responsible for developing  Proper pressure within the container.  Provide driving force to expel the  product from the container. TYPES OF PROPELLANTS  Liquefied gases Propellants  Compressed gases Propellants
  • 7. LIQUIDFIED GASES PROPELLANTS  Liquified propellants are gases that exist as liquids under pressure.  Because the aerosol is under pressure propellant exists mainly as a liquid, but it will also be in the head space as a gas.  The product is used up as the valve is opened, some of the liquid propellant turns to gas and keeps the head space full of gas.  In this way the pressure in the can remains essentially constant and the spray performance is maintained throughout the life of the aerosol.
  • 8. CHLORO FLUORO CARBON  Propellant of choice for oral and inhalation . Advantages  Chemical inertness  Lack of toxicity  Non flammability.  Lack of explosiveness Disadvantages  High cost  It depletes the ozone layer Examples: Trichloromonofluoromethane -Propellant11 Dichlorodifluoromethane -Propellant 12 Dichlorotetrafluoroethane- Propellant 114
  • 9. HYDROCARBONS  Can be used for water based aerosols and topical use Advantages  Inexpensive  Excellent solvents  It does not cause ozone depletion Disadvantage  Inflammable  Unknown toxicity produced Example: Propane-propellants A 108  Isobutane-propellant A 31  Butane-propellent A 17
  • 10. HYDROCHLORO CARBON AND HYDRO CHLORO FLUORO CARBANS  These compounds break down in the atmosphere at faster rate than CFCs.  Lower ozone destroying effect. Advantages  Low inhalation toxicity  High chemical stability  High purity  Not ozone depleting Disadvantages  Poor solvent  High cost
  • 11. Example: Heptafluoro propane (HFA-227)  Tetrafluoroethene (HFA-134a)  Difluoroethane- Propellant 152a  Chlorodifluoromethane - Propellant 22  Chlorodifluoromethane - Propellant 142 b  All propellants are designed by three digits(000).  The first digit represents the one less than the number of carbon atoms(‘C’-1) in the compound.  The second digit represents the one more than the number of hydrogen atoms (‘H’+1) in the compound.  The last third digit represents the number of fluorine atoms in the compound.  The number of chlorine atoms (for CFCs) in the compound can be found by subtracting the sum of the fluorine and the hydrogen atoms from the total number of atoms that can be added to saturated the carbon chain.  In case of isomers, the most symmetrical one is indicated by the number alone. As the isomer becomes more and more asymmetrical, the letter a, b, c etc. follows the number.  For cyclic compound, a lowercase c is used before the number.
  • 12. COMPRESSED GAS PROPALLENT  Compressed gas propellants occupy the head space above the liquid in the can.  When the aerosol valve is opened the gas 'pushes' the liquid out of the can.  The amount of gas in the headspace remains the same but it has more space, and as a result the pressure will drop during the life of the can.  Spray however by careful choice of the aerosol valve and actuator.  They must be able to withstand pressures as high as 140 to 180 psig (pounds per sq. inch gauge) at 130 ° F.
  • 13. AEROSOL CONTAINERS  A . Metals  Tinplated steel  Aluminum  Stainless steel  Glass  Uncoated glass  Plastic coated glass
  • 14. Teen plated steel container  It consist of a sheet of steel plate, this sheet is coated with tin by electrolytic process .  The coated sheet is cut into three pieces ( top , bottom and  body) .  The top, bottom are attached to body by soldering .  When required it is coated with organic material usually  oleoresin, phenolic , vinyl or epoxy coating .  Welding eliminates soldering process, Saves considerable manufacturing time and decreases the product/container interaction.
  • 15. Aluminium container  Used for inhalation and topical aerosols .  Manufactured by impact extrusion process.  Light in weight, less fragile, Less incompatibility due to its seamless nature.  Greater resistance to corrosion.  Pure water and ethanol cause corrosion to the aluminium container.  Added resistance can be obtained by coating inside of the container with organic coating like phenolic , vinyl or epoxy and polyamide resins.
  • 16. Stainless steel container  Used for inhalation aerosols Advantage :  Extremely Strong.  Resistant to many materials.  No need for internal coating Disadvantage :  Costly
  • 17. Glass container  These containers are preferred because of its Aesthetic value and absence of incompatibilities.  These containers are limited to the products having a lower  pressure (33 psig) and lower percentage of the propellant.  Used for topical and MDI aerosols.  Two types of glass aerosol containers- i) Uncoated glass container:  Less cost and high clarity and contents can be viewed at all times. ii) Plastic coated glass containers:  These are protected by plastic coating that prevents the  glass from shattering in the event of breakage.
  • 18. VALVS  Easy to open and close .  Capable of delivering the content in the desired form such  as spray, foam, solid stream etc.  It can deliver a given amount of medicament . TYPES OF VALVES :  Continuous spray valve  Metering valves
  • 20. CONTINUOUS SPRAY VALVE  Used for topical aerosols.  Valves assembly consists:  Ferrule or mounting cup  Valve body or housing  Stem  Dip tube  Gasket  Spring
  • 21. FERRULE OR MOUNTING CUP :  Used to attach valve to container.  Made from Tin plated steel, Al, Brass.  Under side of the valve cup is coated with single or double epoxy or vinyl resins. VALVE BODY OR HOUSING :  Made up of Nylon or Derlin and contains a opening at the  point of attachment of dip tube. (0.013 to 0.080 inch) STEM:  Made from Nylon or Derlin , brass and stainless steel can  also be used. (orifice - 0.013 to 0.030 inch).
  • 22. GASKET:  Made from Buna-N and neoprene rubber. SPRING:  Made from Stainless steel.  Used to hold gasket in place. DIP TUBE:  Made from Poly ethylene or poly propylene.  Inner diameter 0.120 – 0.125 inch.  However, for Capillary dip tube inner diameter is 0.050 inch and for highly viscous products it is 0.195 inch.
  • 23. METERING VALVE  Used for dispensing of potent medication  Operates on theprinciple of a chamber whose size determines the amount of medication dispensed.  Approximately 50 to 150 mg ± 10 % of liquid materials can be dispensed at one time with the use of such valve.
  • 24. ACTUATORS  These are specially designed buttons which helps in delivering the drug in desired form i.e., spray, wet stream, foam or solid stream. TYPES OFACTUATORS:  Spray actuators  Foam actuators  Solid steam actuators  Special actuators
  • 25. SPRAY ACTUATORS:  It can be used for topical preparation, such as antiseptics, local anesthetics and spray on bandages etc.  It allows the stream of product concentrate and propellant to pass through various openings and dispense as spray. FOAM ACTUATORS:  It consists of large orifice which ranges from 0.070—0.125 inch. SOLID STREAM ACTUATORS:  These actuators are required for dispensing semi solid products such as ointments. SPECIALACTUATORS:  These are used for a specific purpose.  It delivers the medicament to the appropriate site of action such as throat, nose, dental and eyes etc.
  • 26. Application of aerosol  The use of aerosol as a dosage foam is particularly important in a administration of drug via a pulmonary system.  In addition to local effects, systemic may be obtain if the drug absorbed in to a bloodstream from the lungs.  Topical preparations are also suited for presentation as aerosol.  They are used for spray bandages and for application of drugs into various body cavities.  They are used for administration of drug such as local anaesthetic, local antiseptic, local analgesics and anti-inflammatory drug.  They are used for cosmetics preparation such as perfumes.  They are used to spray disinfectant, deodorizers, air sanitizers.  The medicament can be delivered to the affect area such as burn and wound.  It also minimizes the discomfort caused by manual and mechanical application.
  • 27. EVALUATION AEROSOL  Aerosol are pressurized packages and many tests are necessary to ensure proper performance of the package and safety during use and storage.  Pharmaceutical aerosols can be evaluated by a series of physical, chemical and biological tests, including: Flammability and combustibility:  Flash point  Flame Projection Physicochemical characteristics:  Vapor pressure  Density  Moisture content  Identification of Propellants  Concentrate- propellent ratio
  • 28. Performance:  Aerosol valve discharge rate  Spray pattern  Dosage with metered valves  Net contents  Foam stability  Particle size determination  Leakage Biological testing:  Therapeutic activity  Toxicity studies
  • 29. Flammability and combustibility: Flash point  Apparatus: Tag Open Cup Apparatus Product is chilled to – 25°F and test liquid  temperature is allowed to increase slowly and the temperature at which vapours ignite is called as Flash Point. Flame Projection  Product is sprayed for 4 secs into a flame and the flame is extended, exact length is measured with a ruler.
  • 30. Property Method 1. Vapor Pressure » Pressure gauge » Can Puncturing Device. 2. Density » Hydrometer, » Pycnometer. 3. Moisture » Karl Fisher Method, » Gas Chromatography. 4. Identification of propellants » Gas Chromatography, » IR Spectroscopy. •Physicochemical characteristics:
  • 31. Performance: Aerosol valve discharge rate  Contents of the aerosol product of known weight is discharged for specific period of time.  By reweighing the container after the time limit, the change in the weight per time dispensed gives the discharge rate (g/sec). Spray pattern  The method is based on the impingement of spray on piece of paper that has been treated with Dye-Talc mixture.  The particles that strike the paper  cause the dye to go into solution and to be adsorbed onto paper giving a record of spray for comparison purpose.
  • 32. Dosage with metered valves  Reproducibility of dosage can be determined by:  »Assay techniques  »Accurate weighing of filled container followed by dispensing of several doses. Containers are then reweighed and difference in weight divided by number of doses dispensed gives average dose. Net Contents:  Tared cans that have been placed onto the filling lines are reweighed and the difference in weight is equal to the net contents.  In Destructive method: weighing a full container and then dispensing as much of the content as possible. The contents are then weighed. This gives the net content.
  • 33. Foam stability  Methods: » Visual Evaluation,  » Time for given mass to penetrate the foam,  » Time for given rod that is inserted into the foam to fall,  » Rotational Viscometer. Particle Size Determination  Methods: » Cascade Impactor,  » Light Scattering Decay.
  • 34. Biological testing: Therapeutic Activity  » For Inhalation Aerosols: dosage of the product is determined and is related to the particle size distribution.  » For Topical Aerosols: is applied to test areas and adsorption of therapeutic ingredient is determined. Toxicity  » For Inhalation Aerosols: exposing test animals to vapours sprayed from aerosol container  » For Topical Aerosols: : Irritation and Chilling effects are determined.
  • 35. QUALITY CONTROL TEST OFAEROSOL  There are following quality control test for aerosol: -Propellants -Valves, Actuators and Dip Tubes -Containers -Weight Checking -Leak Testing -Spray Testing
  • 36. Propellants  Vapor pressure and density of the propellant are determined and compared with specification sheet. Parameter Tested By • Identification • Purity and acceptability Gas Chromatography, IR Spectroscopy Moisture, Halogen, Non-Volatile Residue determinations
  • 37. Valves, Actuators and Dip Tubes  Sampling is done according to standard procedures as found in Military Standards ―MIL-STD-105D‖.  For metered dose aerosol valves, test methods were developed by -Aerosol Specifications Committee -Industrial Pharmaceutical Technology Section -Academy of Pharmaceutical Sciences.  The objective of this test is to determine magnitude of valve delivery & degree of uniformity between individual valves.  Standard test solutions were proposed to rule out variation in valve delivery.
  • 38. CONTAINERS  Containers are examined for defects in lining.  Quality control aspects includes degree of conductivity of  electric current as measure of exposed metals.  Glass containers examined for Flaws. WEIGHT CHECKING  Is done by periodically adding to the filling line tared empty aerosol containers, which after filling with concentrate are removed & weighed.  Same procedure is used for checking weight of Propellants being added.
  • 39. LEAK TESTING  It is a means of checking crimping of the valve and detect the defective containers due to leakage.  Is done by measuring the Crimp ‘s dimension & comparing.  Final testing of valve closure is done by passing the filled containers through water bath. SPRAY TESTING  Most pharmaceutical aerosols are 100% spray tested.  This serves to clear the dip tube of pure propellant and pure concentrate.  To check for defects in valves and spray pattern.